Extended Research Article
Omalizumab for severe atopic dermatitis in 4- to 19-year-olds: the ADAPT RCT
Susan MH Chan
,
Suzie Cro
,
Victoria Cornelius
,
Rahi Jahan
,
Suzana Radulovic
,
Gideon Lack
-
Journal:
Efficacy and Mechanism Evaluation Volume: 9, Issue: 5
-
Published:
6 June 2022